Cargando...
Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B
BACKGROUND & AIMS: To evaluate virological breakthrough (VBT) and the risk of hepatocellular carcinoma (HCC) in HBeAg-positive chronic hepatitis B (CHB) patients receiving entecavir (ETV) treatment. METHODS: A retrospective cohort study was conducted in a tertiary referral hospital and a total o...
Guardado en:
| Publicado en: | PLoS One |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716625/ https://ncbi.nlm.nih.gov/pubmed/31469875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0221958 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|